You just read:

Rich Pharmaceuticals Retains Contract Research Organization, CMIC, to Manage Upcoming Phase 1/2 Clinical Trial for its Acute Myelocytic Leukemia (AML) and Myelodysplastic Syndrome (MDS) Drug in Thailand

News provided by

Rich Pharmaceuticals, Inc.

Apr 04, 2016, 09:45 ET